Skip to main content

María Nieves Larrosa Escartin

I have a degree in Medicine and Surgery from the University of Zaragoza and a PhD in Microbiology from the Autonomous University of Barcelona. I completed the residency period (MIR) at the Microbiology Service of the Vall d'Hebron University Hospital, where I currently work as a clinical head. In addition, I am a researcher at the Vall d'Hebron Research Institute (VHIR) and a teacher in the Department of Genetics and Microbiology of the Autonomous University of Barcelona.

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca
Head of Department
Microbiology
Cross-departmental services

María Nieves Larrosa Escartin

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca
Head of Department
Microbiology
Cross-departmental services

I have a degree in Medicine and Surgery from the University of Zaragoza and a PhD in Microbiology from the Autonomous University of Barcelona. I completed the residency period (MIR) at the Microbiology Service of the Vall d'Hebron University Hospital, where I currently work as a clinical head. In addition, I am a researcher at the Vall d'Hebron Research Institute (VHIR) and a teacher in the Department of Genetics and Microbiology of the Autonomous University of Barcelona.

Knowledge areas:
Antimicrobial resistance and control of Healthcare-associated infection, especially in critically ill patients. Diagnosis of sepsis and implementation of rapid diagnostic techniques that contribute effectively to the optimization of antimicrobial treatment (Antimicrobial Stewardship Programs or ASP)
Member of commissions and subcommittees of the hospital, various scientific groups and professional societies.

Research activity:
PI of two competitive projects financed by the Fondo de Investigaciones Sanitarias that study the dynamics of transmission of multidrug-resistant bacteria and the individualization of isolation policies based on the epidemic risk.
Researcher of the Collaborative Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain. CB21/13/00054.
Author or co-author of numerous articles published in national and international journals.

Teaching activity:
Professor of Medical Microbiology and Parasitology at the Universitat Autònoma de Barcelona since 2007, teaching in Medicine and Biomedicine Degrees and various collaborative master's degrees with other Universities.

Research lines

Antimicrobial Resistance

Antimicrobial resistance is one of the main public health problems recognized by the main public health and sanitary agencies. Enterobacters such as Escherichia coli and Klebsiella pneumoniae, and other bacterial species such as Pseudomonas aeruginosa or Staphylococcus aureus are among the main pathogens causing infections and deaths associated with antimicrobial resistance.


Our research group works on the study of the mechanisms of action and resistance to antimicrobials of these and other bacteria of clinical interest, as well as the study of the mobile genetic elements where their resistance determinants can be found and possible therapeutic alternatives that can be considered to treat the infections they produce. Likewise, we work on the development, application and implementation of state-of-the-art processes, analysis and technologies that allow us to identify the molecular epidemiology, distribution and population structure of multi-resistant bacteria in order to early detect the emergence of high-risk epidemiological clones that can be transferred between patients, producing infections and/or outbreaks related to healthcare.

IP: Juan Jose Gonzalez Lopez, María Nieves Larrosa Escartin

Sepsis

IP: María Nieves Larrosa Escartin, Juan Jose Gonzalez Lopez

Projects

Screening of new precision antibiotics for the treatment of multiresistant infections (ABPATHFINDER)

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Alba Mir Cros, Albert Moreno Mingorance
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: D7357
Duration: 02/01/2023 - 31/12/2024

Development of a new intelligent and predictive tool for the early diagnosis and improved treatment of sepsis.

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Ricard Ferrer Roca, Juan Carlos Ruiz Rodriguez, Josep Roca Grande
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 339371
Reference: CPP2021-008464
Duration: 14/02/2022 - 13/02/2025

Ministerio de Ciencia

Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron

IP: Juan Jose Gonzalez Lopez
Collaborators: María Nieves Larrosa Escartin, Gema Codina Grau, Virginia Rodríguez Garrido, Andres Antón Pagarolas, Juliana Esperalba Esquerra, Ariadna Rando Segura, Alba Mir Cros, Yannick Hoyos Mallecot, Joan Joseph Munné, Tomàs Pumarola Suñé, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Albert Moreno Mingorance, Maria Piñana Moro, Aroa Silgado Gimenez, Elena Sulleiro Igual, Lidia Goterris Bonet, Josep Roca Grande, Alejandra Gonzalez Sánchez, Narcís Saubí Roca, Jesus Trejo Zahinos
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01129
Duration: 01/01/2022 - 30/06/2025

CIBER Malalties Infeccioses

IP: Juan Jose Gonzalez Lopez
Collaborators: Benito Almirante Gragera, María Nieves Larrosa Escartin, Oscar Len Abad, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Javier Gomis Rodriguez, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, Laura Escola Verge, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 100500
Reference: CB21/13/00054
Duration: 01/01/2022 - 31/12/2022

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Janna Anthonina Slabbekoorn

Janna Anthonina Slabbekoorn

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Maria Francesca Cortese

Maria Francesca Cortese

Main researcher
Microbiology
Read more
Efráin Santiago Cordero Vázquez

Efráin Santiago Cordero Vázquez

Predoctoral researcher
Diabetes and Metabolism
Read more
Matteo Pusceddu

Matteo Pusceddu

Postdoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.